Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study.

Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA.

PLoS One. 2010 Oct 20;5(10):e13496. doi: 10.1371/journal.pone.0013496.

2.

Functional polymorphism of the renalase gene is associated with cardiac hypertrophy in female patients with aortic stenosis.

Orlowska-Baranowska E, Gadomska Vel Betka L, Gora J, Baranowski R, Pedzich-Placha E, Zakrzewski D, Dlugosz A, Kossowska H, Zebrowska A, Zakoscielna E, Janiszewska A, Hryniewiecki T, Gaciong Z, Placha G.

PLoS One. 2017 Oct 24;12(10):e0186729. doi: 10.1371/journal.pone.0186729. eCollection 2017.

3.

Renalase gene polymorphism in patients after renal allograft transplantation.

Pawlik A, Serdynska M, Dabrowska-Zamojcin E, Dziedziejko V, Safranow K, Domanski L, Ciechanowski K.

Kidney Blood Press Res. 2014;39(1):58-64. doi: 10.1159/000355777. Epub 2014 Jun 3.

4.

The association study on renalase polymorphism and hypertension: a meta-analysis.

Shi WB, Wang HY.

Int J Clin Exp Med. 2015 Jun 15;8(6):9505-11. eCollection 2015.

5.

Novel insights into the physiology of renalase and its role in hypertension and heart disease.

Desir G.

Pediatr Nephrol. 2012 May;27(5):719-25. doi: 10.1007/s00467-011-1828-7. Epub 2011 Mar 20. Review.

PMID:
21424526
6.

Role of renalase in the regulation of blood pressure and the renal dopamine system.

Desir GV.

Curr Opin Nephrol Hypertens. 2011 Jan;20(1):31-6. doi: 10.1097/MNH.0b013e3283412721. Review.

PMID:
21099685
7.

Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke.

Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A.

Neuromolecular Med. 2011 Dec;13(4):321-7. doi: 10.1007/s12017-011-8158-6. Epub 2011 Oct 2.

8.

Renalase deficiency aggravates ischemic myocardial damage.

Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D, Sampaio-Maia B, Quelhas-Santos J, Russell K, Russell R, Flavell RA, Pestana M, Giordano F, Desir GV.

Kidney Int. 2011 Apr;79(8):853-60. doi: 10.1038/ki.2010.488. Epub 2010 Dec 22.

10.

Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension.

Stec A, Semczuk A, Furmaga J, Ksiazek A, Buraczynska M.

Nephrol Dial Transplant. 2012 Nov;27(11):4162-6. doi: 10.1093/ndt/gfr293. Epub 2011 May 26.

PMID:
21617193
11.

Association of Renalase SNPs rs2296545 and rs2576178 with the Risk of Hypertension: A Meta-Analysis.

Lv YB, Wang Y, Ma WG, Yan DY, Zheng WL, Chu C, Guo TS, Yuan ZY, Mu JJ.

PLoS One. 2016 Jul 19;11(7):e0158880. doi: 10.1371/journal.pone.0158880. eCollection 2016.

12.

Renalase gene polymorphism and epinephrine level in chronic kidney disease.

Rezk NA, Zidan HE, Elnaggar YA, Ghorab A.

Appl Biochem Biotechnol. 2015 Feb;175(4):2309-17. doi: 10.1007/s12010-014-1433-x. Epub 2014 Dec 9.

PMID:
25484193
13.

The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmö Diet and cancer study.

Fava C, Montagnana M, Danese E, Sjögren M, Almgren P, Engström G, Hedblad B, Guidi GC, Minuz P, Melander O.

BMC Med Genet. 2012 Jul 19;13:57.

14.

Renalase is a novel target gene of hypoxia-inducible factor-1 in protection against cardiac ischaemia-reperfusion injury.

Du M, Huang K, Huang D, Yang L, Gao L, Wang X, Huang D, Li X, Wang C, Zhang F, Wang Y, Cheng M, Tong Q, Qin G, Huang K, Wang L.

Cardiovasc Res. 2015 Feb 1;105(2):182-91. doi: 10.1093/cvr/cvu255. Epub 2014 Dec 11.

PMID:
25497549
15.

Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study.

Farzaneh-Far R, Na B, Schiller NB, Whooley MA.

Atherosclerosis. 2009 Aug;205(2):492-6. doi: 10.1016/j.atherosclerosis.2008.12.026. Epub 2008 Dec 30.

16.

Rs10887800 renalase gene polymorphism is associated with an increased risk of coronary artery disease in hemodialyzed patients.

Stec A, Ksiazek A, Buraczynska M.

Int Urol Nephrol. 2016 Jun;48(6):871-6. doi: 10.1007/s11255-016-1270-7. Epub 2016 Mar 29.

17.

Renalase gene polymorphism in patients with hypertension and concomitant coronary heart disease.

Li X, Jiang W, Li L, Huang R, Yang Q, Yang Y, Hong Y, Tang X.

Kidney Blood Press Res. 2014;39(1):9-16. doi: 10.1159/000355771. Epub 2014 Apr 30.

18.

Left ventricular function and exercise capacity.

Grewal J, McCully RB, Kane GC, Lam C, Pellikka PA.

JAMA. 2009 Jan 21;301(3):286-94. doi: 10.1001/jama.2008.1022.

19.

N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.

Singh HS, Bibbins-Domingo K, Ali S, Wu AH, Schiller NB, Whooley MA.

Clin Cardiol. 2009 Aug;32(8):447-53. doi: 10.1002/clc.20569.

20.

Resistin, exercise capacity, and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study.

Zhang MH, Na B, Schiller NB, Whooley MA.

Atherosclerosis. 2010 Dec;213(2):604-10. doi: 10.1016/j.atherosclerosis.2010.09.015. Epub 2010 Sep 24.

PMID:
20951381

Supplemental Content

Support Center